嘌呤生物合成在持续性耐甲氧西林金黄色葡萄球菌感染中的作用
本研究探讨持续性耐甲氧西林金黄色葡萄球菌(MRSA)菌血症的遗传机制。与缓解性菌血症分离株相比,持续性菌株的关键毒力调节子及结构基因激活更早,嘌呤生物合成基因表达更高,生长更快且更早进入稳定期;同源菌株及抑制剂实验提示嘌呤生物合成与体内持续结局存在因果关系。
要点
- 持续性MRSA菌株较缓解性菌株更早激活sigB、sarA、sae、cap5等关键毒力调节子及结构基因。
- 持续性菌株嘌呤生物合成基因(如purF)表达更高,生长更快且更早进入稳定期。
- 同源purF突变株及嘌呤生物合成抑制剂实验提示嘌呤生物合成与体内持续结局存在因果关系。
核心结论
- 嘌呤生物合成在持续性MRSA菌血症结局中起关键作用,并可能成为提高危及生命MRSA感染疗效的新靶点。
研究设计与样本
- 本研究比较持续性MRSA菌血症(PB)与缓解性菌血症(RB)分离株,并采用同源野生型MRSA、purF突变株及purF互补株和嘌呤生物合成抑制剂进行机制研究。
- PB定义为治疗开始后≥7天血培养仍阳性;RB定义为治疗开始后2-4天血培养转阴。
主要发现
- 与RB分离株相比,PB菌株更早激活关键毒力调节子及结构基因(如sigB、sarA、sae和cap5),嘌呤生物合成基因(如purF)表达更高,生长更快且更早进入稳定期。
- 同源菌株集(野生型MRSA、purF突变株、purF互补株)及嘌呤生物合成抑制剂的实验提示嘌呤生物合成与体内持续结局存在因果关系。
临床怎么用
- 作者认为嘌呤生物合成可能成为提高危及生命MRSA感染疗效的新靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia (PB) represents an important subset of S. aureus endovascular infections. In this study, we investigated potential genetic mechanisms underlying the persistent outcomes. Compared with resolving bacteremia (RB) isolates (defined as isolates associated with negative results of blood cultures 2-4 days after initiation of therapy), PB strains (defined as isolates associated with positive results of blood cultures ≥7 days after initiation of therapy) had significantly earlier onset activation of key virulence regulons and structural genes (eg, sigB, sarA, sae, and cap5), higher expression of purine biosynthesis genes (eg, purF), and faster growth rates, with earlier entrance into stationary phase. Importantly, an isogenic strain set featuring a wild-type MRSA isolate, a purF mutant strain, and a purF-complemented strain and use of strategic purine biosynthesis inhibitors implicated a causal relationship between purine biosynthesis and the in vivo persistent outcomes. These observations suggest that purine biosynthesis plays a key role in the outcome of PB and may represent a new target for enhanced efficacy in treating life-threatening MRSA infections.
引用
- Li L, Abdelhady W, Donegan NP, et al. Role of Purine Biosynthesis in Persistent Methicillin-Resistant Staphylococcus aureus Infection. J Infect Dis. 2018. PMID: 29868791. doi:10.1093/infdis/jiy340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。